Bladder Cancer Clinical Trial

Bladder Bank (a Prospective Banking Study)

Summary

This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.

View Full Description

Full Description

PRIMARY OBJECTIVE:

I. To establish a biobank of samples (blood and urine) to support the development of non-invasive tests for early detection of bladder cancer.

OUTLINE: This is an observational study.

Patients undergo blood and urine sample collection and have their medical records reviewed while on study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age > 18 years
Patient has undergone office-based evaluation for hematuria (computed tomography [CT], ultrasound, cystoscopy)

Exclusion Criteria:

Patient has known cancer outside of the target cancer 5 years prior to current collection (not including basal cell or squamous cell skin cancers; if patient has not been seen or if information is not available, the patient is eligible)
Patient has recurrent muscle invasive bladder cancer
Patient has ever been previously diagnosed with UTUC (upper tract urothelial carcinoma) prior to bladder resection
Patient has received chemotherapy class drugs for the treatment of non-target origin cancer in the 5 years prior to current collection
Patient has had any prior radiation therapy to the target lesion prior to current collection
Patient has had a biopsy to the target organ and/or lesion within 3 days before collection
Patient has undergone cystectomy
Patient has transurethral instrumentation (placement of urinary catheter) within 7 days prior to urine collection
Patient has had a urinary tract infection within 14 days prior to urine collection
Patient has chronic indwelling urinary catheter
Patient has prior diagnosis of bladder cancer for which prior resection of tumor was performed

Study is for people with:

Bladder Cancer

Estimated Enrollment:

500

Study ID:

NCT06109857

Recruitment Status:

Recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic in Rochester
Rochester Minnesota, 55905, United States More Info
Clinical Trials Referral Office
Contact
855-776-0015
[email protected]
John B. Kisiel, M.D.
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

500

Study ID:

NCT06109857

Recruitment Status:

Recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.